Navios Maritime Holdings Inc (NM) Jumps 9.43% on December 24

Equities Staff |

Navios Maritime Holdings Inc (NM) was among the biggest gainers on the Russell 2000 for Thursday December 24 as the stock popped 9.43% to $1.74, representing a gain of $0.15 per share. Some 819,905 shares traded hands on 2,284 trades, compared with an average daily volume of 911,383 shares out of a total float of 108.13 million. The stock opened at $1.59 and traded with an intraday range of $1.75 to $1.57.

After today's gains, Navios Maritime Holdings Inc reached a market cap of $188.14 million. Navios Maritime Holdings Inc has had a trading range between $4.68 and $1.13 over the last year, and it had a 50-day SMA of $1.76 and a 200-day SMA of $3.03.

Navios Maritime Holdings Inc is a seaborne shipping and logistics company focused on the transport and transshipment of drybulk commodities including iron ore, coal and grain. It operates in two segments; Dry bulk Vessel Operations and Logistics.

Navios Maritime Holdings Inc is based out of Monte Carlo, and has some 562 employees. Its CEO is Angeliki Frangou.

For a complete fundamental analysis analysis of Navios Maritime Holdings Inc, check out Equities.com’s Stock Valuation Analysis report for NM. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…